MEET OUR EXPERT AUTHORS aND REVIEWERS
Editorial Team and Medical Review Board
At AllAboutPeptides, every article is created and reviewed by a dedicated team of medical professionals, science writers, and subject matter experts who share our commitment to making complex peptide research accessible and accurate.
Our editorial board carefully vets each piece of content against peer-reviewed literature and clinical studies to ensure you receive reliable, science-backed information you can trust. From medical fact-checkers to specialized writers with backgrounds in health, our team works collaboratively to deliver the clarity and credibility that sets us apart in a field often clouded by hype and unverified claims.
Dr. Michael Fortunato, MD
Dr. Michael Fortunato, MD, earned his medical degree from the University of Nevada, Reno, following his Bachelor of Arts in Philosophy with a minor in Biology from UNLV. He completed his anesthesiology residency at Penn State University, where he developed his foundation in evidence-based clinical practice.
Dr. Fortunato holds dual board certifications in anesthesiology and hormone optimization, complemented by advanced certification in Bioidentical Hormone Replacement Therapy (BHRT) through WorldLink Medical. His distinctive academic foundation in philosophy enhances his analytical approach to medical literature and content review.
Currently practicing with a focus on hormone optimization protocols and peptide therapies, Dr. Fortunato combines his clinical expertise with rigorous academic standards to ensure our editorial content meets the highest levels of medical accuracy and clinical relevance. His integrative approach to medicine and commitment to personalized patient care inform his editorial oversight of health optimization content.
Ryan Molony, PhD
Ryan Molony, PhD, is a biomedical researcher and scientific editor with advanced training in immunology and cell biology. He earned his PhD in Immunology at Yale University, where he conducted research in the Iwasaki Lab, and also holds an MS in Biology from Yale and a BS in Cell Biology from the University of Connecticut.
He spent four years at the Novartis Institutes for Biomedical Research working in oncology, with experience in drug development, translational science, and experimental biology. This background supports careful evaluation of how preclinical findings translate into clinical research and therapeutic use.
Dr. Molony has published in peer-reviewed journals including Science, Nature Reviews Immunology, and Frontiers in Immunology, and has edited thousands of scientific and medical documents for academic and industry clients. His work focuses on immunology, cell signaling, pharmaceutical development, and experimental design, with an emphasis on accuracy, clarity, and responsible interpretation of biomedical research used in educational health content.
Christelle Tsasa, BS
Christelle Tsasa is a biochemistry graduate and clinical research professional with experience supporting Phase I–III clinical trials across academic and hospital-based research settings. She earned a Bachelor of Science in Biochemistry from the University of Nevada, Las Vegas, and has worked on both drug and medical device studies.
Her background includes protocol review, data management across clinical research platforms, and collaboration with multidisciplinary research teams. She has experience working with electronic systems commonly used in clinical research, including REDCap, EPIC, and electronic data capture platforms, and is familiar with regulatory and ethical considerations that govern human subjects research.
Christelle supports scientific writing and editorial review by applying her training in clinical research methodology, regulatory principles, and critical evaluation of biomedical literature. Her work focuses on ensuring accuracy, clarity, and responsible interpretation of research used in educational health content.
Tanner Wetzal, DO/PhD Candidate
Tanner Wetzal is a dual-degree medical scholar completing a Doctor of Osteopathic Medicine and a PhD at Des Moines University. His training spans biomedical sciences, immunology, pharmacology, physiology, and cancer biology, supported by a Master of Public Health from the University of Nebraska Medical Center and a Bachelor of Science in Biotechnology from South Dakota State University.
His doctoral research includes in vivo and in vitro studies, bioinformatic analysis, and work in tumor immunology and biochemical pathways, providing a strong foundation for evaluating how molecular and pharmacologic research translates into clinical use.
Tanner has more than seven years of experience in medical and scientific writing, including academic manuscripts, technical reviews, and research summaries. His clinical background includes work in intensive care units as a patient care technician, along with prior experience as a certified nursing and medication assistant. He supports editorial review by assessing research accuracy, study design, and clinical relevance, and by communicating medical information with clarity and care.
Kevin Schaeffer
Kevin Schaeffer is a health writer and independent researcher focused on peptides, mental health, addiction recovery, and psychedelic-assisted therapy. His work examines how emerging therapies intersect with neuroscience, behavior change, and recovery, with careful attention to published research and appropriate interpretation of evidence.
Drawing on scientific literature and lived experience, Schaeffer writes about alternative treatment models in a clear, measured voice suited to complex and sensitive subjects. His articles have appeared across health and wellness platforms covering addiction treatment, mental health education, and personal development.
He has experience producing digital health content and long-form educational writing, translating technical material into accessible explanations without overstating claims. Earlier in his career, he founded and operated a small herbal supplement business, gaining firsthand exposure to natural products, consumer education, and regulatory considerations. Kevin holds a degree in Hospitality Management from Northern Arizona University and contributes research-informed content that supports scientific literacy and informed decision-making.
Join the Research Peptide Community
Evidence-based peptide education, clinical insights, and longevity protocols delivered weekly to your inbox.